• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15922 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Assessment of bilateral cochlear implants in children. Indication criteria for cochlear implants in children and adults]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Positron emission tomography: proposal for prioritization of indications]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Efficiency in the use of operating surgical blocks. Definition of indicators]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Development of a basic set of expert consensus-based quality indicators for the care delivered to stroke patients]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Total hip and knee artroplasties in Catalonia. Effectiveness and safety]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Everolimus (Afinitor) for the treatment of renal cell carcinoma]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Lapatinib (Tyverb) for the treatment of metastatic breast cancer]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Ofatumumab (Arzerra®) for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Tolvaptan (Samsca) for the treatment of hyponatremia associated with the syndrome of inappropriate antidiuretic hormone secretion]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Enzymatic replacement treatment for type I gaucher's disease patients]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical Practice Guideline on the care for people with alzheimer's disease and dementia]
2011 Medical Advisory Secretariat (MAS) Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis
2011 Medical Advisory Secretariat (MAS) Diurnal tension curves for assessing the development or progression of glaucoma: an evidence-based analysis
2011 HAYES, Inc. Alport syndrome
2011 The Swedish Council on Health Technology Assessment (SBU) [Analysis of fetal DNA in maternal blood: non-invasive fetal diagnostic tests for blood group and sex determination]
2011 The Swedish Council on Health Technology Assessment (SBU) [Computer-Aided Detection (CAD) in mammography screening]
2011 The Swedish Council on Health Technology Assessment (SBU) [Molecular diagnostic tests for men at higher probability for prostate cancer]
2011 Health Information and Quality Authority (HIQA) A health technology assessment of prion filtration of red cell concentrates to reduce the risk of variant Creutzfeldt-Jakob disease transmission in Ireland
2011 Agency for Healthcare Research and Quality (AHRQ) Evaluation of effectiveness and safety of antiepileptic medications in patients with epilepsy
2011 Agency for Healthcare Research and Quality (AHRQ) Diagnosis and treatment of obstructive sleep apnea in adults
2011 Medical Services Advisory Committee (MSAC) Measurement and determination of Procalcitonin (PCT)
2011 Health Intervention and Technology Assessment Program (HITAP) [Designing a decision frame for making health resource allocation decisions: a case study in Thailand]
2011 Health Intervention and Technology Assessment Program (HITAP) [Cost-benefit analysis of prenatal screening and diagnosis for Down syndrome in Thailand]
2011 Health Intervention and Technology Assessment Program (HITAP) Cost-utility analysis of adjuvant therapy for stage III colorectal cancer in Thailand]
2011 Health Intervention and Technology Assessment Program (HITAP) [School-based screening for Attention Deficit and Hyperactivity Disorder (ADHD) and Learning Disorders (LD)]
2011 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Prevention of alcohol misuse among children, youths and young adults]
2011 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Prostate cancer screening
2011 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Nasopharyngeal carcinoma screening
2011 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) HPV DNA-based screening test for cervical cancer
2011 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Immunochemical faecal occult blood test (IFOBT) for colorectal cancer screening
2011 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Pharyngeal pH monitoring by Dx-pH measurement system]
2011 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Effectiveness and safety of electrochemotherapy tumor treatment: Systematic review and meta-analysis]
2011 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Computerised cognitive behavioural therapy for adults with depression
2011 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Transnasal oesophagoscopy (TNE)
2011 Medical Advisory Secretariat (MAS) Continuous glucose monitoring for patients with diabetes
2011 Committee for New Health Technology Assessment (CNHTA) [Sialendoscopy]
2011 Committee for New Health Technology Assessment (CNHTA) [Debridement using hydrosurgery system]
2011 Committee for New Health Technology Assessment (CNHTA) [Camera manipulating robot assisted endoscopic surgery]
2011 Committee for New Health Technology Assessment (CNHTA) [Transanal radiofrequency treatment of fecal incontinence]
2011 Committee for New Health Technology Assessment (CNHTA) [autologous platelet rich plasma application]
2011 Committee for New Health Technology Assessment (CNHTA) [HBV entecavir resistance mutation [PCR-RFMP]]
2011 Committee for New Health Technology Assessment (CNHTA) [BRAF Gene, Mutation(Peptide Nucleic Acid Mediated Real-time PCR Clamping Method)]
2011 Committee for New Health Technology Assessment (CNHTA) [Urine neural thread protein]
2011 Committee for New Health Technology Assessment (CNHTA) [I-125 permanent implant for prostate cancer]
2011 Committee for New Health Technology Assessment (CNHTA) [Non-invasive cardiac output monitoring by bioreactance technology]
2011 Committee for New Health Technology Assessment (CNHTA) [Enterovirus real-time rt-pcr]
2011 Committee for New Health Technology Assessment (CNHTA) [Urine neural thread protein test]
2011 Committee for New Health Technology Assessment (CNHTA) [Deletion of 18q choromosome in colorectal cancer (LOH, loss of heterozygosity)]
2011 Committee for New Health Technology Assessment (CNHTA) [Photodynamic therapy for bladder, cervix and lung cancer]
2011 Committee for New Health Technology Assessment (CNHTA) [C-11-acetate positron emission tomography, positron emission tomography/computed tomography]
2011 Committee for New Health Technology Assessment (CNHTA) [Intraoperative Radiotherapy with Low Energy X-rays]
2011 Committee for New Health Technology Assessment (CNHTA) [Microvolt T-wave alternans system]
2011 Belgian Health Care Knowledge Centre (KCE) Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium - Part 2
2011 Belgian Health Care Knowledge Centre (KCE) Home oxygen therapy
2011 Belgian Health Care Knowledge Centre (KCE) Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood
2011 Finnish Office for Health Care Technology Assessment (Finohta) [Bioimpedance in the estimation of dry weight in hemodialysis patients]
2011 Finnish Office for Health Care Technology Assessment (Finohta) [Continuous wound infusion of local anaesthetic agents for postoperative analgesia]
2011 Finnish Office for Health Care Technology Assessment (Finohta) [CT colonography as a diagnostic method in colonic diseases]
2011 Finnish Office for Health Care Technology Assessment (Finohta) [Paclitaxel-coated balloon angioplasty in the treatment of coronary artery disease and peripheral artery stenosis – a systematic review]
2011 Finnish Office for Health Care Technology Assessment (Finohta) [Training surgical skills with computer-based virtual reality simulators]
2011 Finnish Office for Health Care Technology Assessment (Finohta) [Ablation therapy of liver tumors]
2011 Finnish Office for Health Care Technology Assessment (Finohta) [Uterine artery embolisation – an alternative treatment for symptomatic uterine fibroids]
2011 Agency for Healthcare Research and Quality (AHRQ) Outcomes of Sipuleucel-T therapy
2011 Agency for Healthcare Research and Quality (AHRQ) Effectiveness of cochlear implants in adults with sensorineural hearing loss
2011 Agency for Healthcare Research and Quality (AHRQ) Health risk appraisal
2011 Agency for Healthcare Research and Quality (AHRQ) Lifestyle interventions for four conditions: type 2 diabetes, metabolic syndrome, breast cancer, and prostate cancer
2011 Agency for Healthcare Research and Quality (AHRQ) Safety of probiotics used to reduce risk and prevent or treat disease
2011 Agency for Healthcare Research and Quality (AHRQ) Enabling medication management through health information technology
2011 Agency for Healthcare Research and Quality (AHRQ) A framework for "best evidence" approaches in systematic reviews
2011 Agency for Healthcare Research and Quality (AHRQ) Health literacy interventions and outcomes: an updated systematic review
2011 Health Services Assessment Collaboration (HSAC) Systematic review of systems of palliative care
2011 Medical Advisory Secretariat (MAS) Emerging pharmacogenomic tests
2011 Institute for Clinical Evaluative Sciences (ICES) Geographic access to primary care and hospital services for rural and northern communities: Report to the Ontario Ministry of Health and Long-Term Care.
2011 Institute for Clinical Evaluative Sciences (ICES) Economic evaluation of percutaneous coronary intervention in stable coronary artery disease: studies in utilities, costs and decision modelling
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Vancomycin or metronidazole for treatment of clostridium difficile infection: clinical and economic analyses
2011 Health Council of the Netherlands Gezondheidsraad (GR) Vaccination of young children against tuberculosis
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Alglucosidase alpha (Myozyme) for treatment of patients with late-onset Pompe disease]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Miglustat (Zavesca) for patients with type 1 Gaucher's disease]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Pazopanib (Votrient) for the treatment of patients with advanced renal cell carcinoma]
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Trabectedin (Yondelis) for the treatment of ovarian cancer]
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Facet joint injection as diagnostic and therapeutic tools for pain of the cervical and lumbar spine: a review of clinical and cost-effectiveness
2011 Medical Services Advisory Committee (MSAC) Matrix-induced autologous chondrocyte implantation and autologous chondrocyte implantation
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Robot-assisted surgery versus open surgery and laparoscopic surgery: clinical and cost-effectiveness analyses
2011 Gesundheit Osterreich GmbH (GOeG) [Effectiveness of measures (particularly e-medication) to reduce polypharmacy]
2011 Blue Cross Blue Shield Association (BCBS) Cardiac resynchronization therapy for mild heart failure
2011 Blue Cross Blue Shield Association (BCBS) Fractional flow reserve and coronary artery revascularization
2011 Blue Cross Blue Shield Association (BCBS) Computed tomographic coronary angiography in the evaluation of patients with acute chest pain
2011 Blue Cross Blue Shield Association (BCBS) Special report: maintenance therapy in advanced non-small-cell lung cancer
2011 Blue Cross Blue Shield Association (BCBS) Transcranial magnetic stimulation for depression
2011 Institut national d'excellence en sante et en services sociaux (INESSS) [Indications for positron emission tomography (pet): a brief update]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Impact from HTA-research for the Austrian health care system. Part 2: Results of the empirical survey]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Strengthening the evidence base for a learning health system - Inspirations from good practice for capacity building in health services research and public health research
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ipilimumab for pre-treated patients with advanced/metastatic melanoma
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nilotinib (Tasigna) for the 1st-line treatment of Philadelphia chromosome positive chronic myeloid leukemia in the chronic phase
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cabazitaxel (Jevtana) for the second-line therapy of patients with hormone-refractory metastatic prostate cancer
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Annual Report 2010. German version.]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Annual Report 2010. English version
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Dasatinib (Sprycel) for the first-line therapy of patients with newly diagnosed chronic phase philadelphia chromosome positive chronic myeloid leukemia.
2011 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Diabetic foot ulcers - a health technology assessment]
2011 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Brain injury rehabilitation - a health technology assessment]